Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemini in Stage 3-4 Chronic Kidney Disease
NCT06863467Phase 2Completed
- Sponsor
- Revelation Biosciences
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Gemini in chronic kidney disease (CKD), sponsored by Revelation Biosciences. Started Jan 2025; status: completed.
02
Drugs
Gemini
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT06863467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06863467.